Standard clinical trial designs aim to determine whether a treatment is beneficial, on average, for a target population. Such trials can have low power if the treatment only benefits a subpopulation, for example, that adaptively change enrollment criteria during a trial, called adaptive enrichment designs, have potential to provide improved information about which subpopulations benefit from new treatments.
